Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,362 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Not Yet Recruiting

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

NCT07527325

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States

View Trial Details

Not Yet Recruiting

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

NCT07621614

Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

NCT07619898

Conditions: Colitis, Colonic Diseases, Digestive System Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma

NCT07615881

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

NCT07340619

Conditions: Melanoma, Metastatic (Stage IV) Melanoma, Neoplasm Metastasis, +14 more
Locations: Institut Bergonie Bordeaux, France

Centre Leon Berard Lyon, France

Institut Paoli Calmettes Marseille, France

Centre Antoine Lacassagne Nice, France

View Trial Details

Not Yet Recruiting

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

NCT07581509

Conditions: Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings), Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not Yet Recruiting

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

NCT07444606

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

NCT07552597

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

NCT07517653

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details